The prior authorization cost control process can be a burden on clinicians and lead to delayed treatment for patients. But the AMA’s recent advocacy efforts may help reform the process. Dr. Charles Turck meets with Emily Carroll, Heather McComas, and Chris Sherin to dive into these reforms and their impact at the state and federal levels.